132 related articles for article (PubMed ID: 15736482)
1. Loss of heterozygosity at chromosomes 3p and 17p in primary non-small cell lung cancer.
Chmara M; Wozniak A; Ochman K; Kobierska G; Dziadziuszko R; Sosinska-Mielcarek K; Jassem E; Skokowski J; Jassem J; Limon J
Anticancer Res; 2004; 24(6):4259-63. PubMed ID: 15736482
[TBL] [Abstract][Full Text] [Related]
2. Loss of heterozygosity at 3p in non-small cell lung cancer and its prognostic implication.
Mitsudomi T; Oyama T; Nishida K; Ogami A; Osaki T; Sugio K; Yasumoto K; Sugimachi K; Gazdar AF
Clin Cancer Res; 1996 Jul; 2(7):1185-9. PubMed ID: 9816286
[TBL] [Abstract][Full Text] [Related]
3. High resolution chromosome 3p allelotyping of human lung cancer and preneoplastic/preinvasive bronchial epithelium reveals multiple, discontinuous sites of 3p allele loss and three regions of frequent breakpoints.
Wistuba II; Behrens C; Virmani AK; Mele G; Milchgrub S; Girard L; Fondon JW; Garner HR; McKay B; Latif F; Lerman MI; Lam S; Gazdar AF; Minna JD
Cancer Res; 2000 Apr; 60(7):1949-60. PubMed ID: 10766185
[TBL] [Abstract][Full Text] [Related]
4. Correlation of abnormal RB, p16ink4a, and p53 expression with 3p loss of heterozygosity, other genetic abnormalities, and clinical features in 103 primary non-small cell lung cancers.
Geradts J; Fong KM; Zimmerman PV; Maynard R; Minna JD
Clin Cancer Res; 1999 Apr; 5(4):791-800. PubMed ID: 10213214
[TBL] [Abstract][Full Text] [Related]
5. [Prognostic value of heterozygosity loss in chromosome 3p in non-microcytic bronchogenic carcinoma].
Maestro ML; Izquierdo L; Sánchez-Pernaute A; Sanz Casla MT; González S; Torres A; del Barco V; Gómez A; Pérez Aguirre E; Balibrea JL
Med Clin (Barc); 1999 Apr; 112(14):527-9. PubMed ID: 10363238
[TBL] [Abstract][Full Text] [Related]
6. Loss of heterozygosity frequently affects chromosome 17q in non-small cell lung cancer.
Fong KM; Kida Y; Zimmerman PV; Ikenaga M; Smith PJ
Cancer Res; 1995 Oct; 55(19):4268-72. PubMed ID: 7671234
[TBL] [Abstract][Full Text] [Related]
7. Frequent allelic losses on chromosomes 2q, 18q, and 22q in advanced non-small cell lung carcinoma.
Shiseki M; Kohno T; Nishikawa R; Sameshima Y; Mizoguchi H; Yokota J
Cancer Res; 1994 Nov; 54(21):5643-8. PubMed ID: 7923210
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of p53 gene mutation and loss of heterozygosity of 3p, 9p and 17p in precancerous lesions of 29 lung cancer patients.
Nishisaka T; Takeshima Y; Inai K
Hiroshima J Med Sci; 2000 Jun; 49(2):109-16. PubMed ID: 10920577
[TBL] [Abstract][Full Text] [Related]
9. Microsatellite alteration at chromosome 3p loci in neuroendocrine and non-neuroendocrine lung tumors. Histogenetic and clinical relevance.
Hurr K; Kemp B; Silver SA; el-Naggar AK
Am J Pathol; 1996 Aug; 149(2):613-20. PubMed ID: 8701999
[TBL] [Abstract][Full Text] [Related]
10. Allelotype of non-small cell lung carcinoma--comparison between loss of heterozygosity in squamous cell carcinoma and adenocarcinoma.
Tsuchiya E; Nakamura Y; Weng SY; Nakagawa K; Tsuchiya S; Sugano H; Kitagawa T
Cancer Res; 1992 May; 52(9):2478-81. PubMed ID: 1314694
[TBL] [Abstract][Full Text] [Related]
11. Proliferative activity, p53 expression and loss of heterozygosity on 3p, 9p and 17p in atypical adenomatous hyperplasia of the lung.
Kitaguchi S; Takeshima Y; Nishisaka T; Inai K
Hiroshima J Med Sci; 1998 Mar; 47(1):17-25. PubMed ID: 9583279
[TBL] [Abstract][Full Text] [Related]
12. Prognostic implication of microsatellite alteration profiles in early-stage non-small cell lung cancer.
Zhou X; Kemp BL; Khuri FR; Liu D; Lee JJ; Wu W; Hong WK; Mao L
Clin Cancer Res; 2000 Feb; 6(2):559-65. PubMed ID: 10690539
[TBL] [Abstract][Full Text] [Related]
13. Loss of heterozygosity at 9p23 defines a novel locus in non-small cell lung cancer.
Neville EM; Stewart M; Myskow M; Donnelly RJ; Field JK
Oncogene; 1995 Aug; 11(3):581-5. PubMed ID: 7630642
[TBL] [Abstract][Full Text] [Related]
14. Chromosomal duplication accompanies allelic loss in non-small cell lung carcinoma.
Varella-Garcia M; Gemmill RM; Rabenhorst SH; Lotto A; Drabkin HA; Archer PA; Franklin WA
Cancer Res; 1998 Oct; 58(20):4701-7. PubMed ID: 9788625
[TBL] [Abstract][Full Text] [Related]
15. Microsatellite alterations at 5q21, 11p13, and 11p15.5 do not predict survival in non-small cell lung cancer.
Sánchez-Céspedes M; Rosell R; Pifarré A; López-Cabrerizo MP; Barnadas A; Sánchez JJ; Lorenzo JC; Abad A; Monzó M; Navas-Palacios JJ
Clin Cancer Res; 1997 Jul; 3(7):1229-35. PubMed ID: 9815804
[TBL] [Abstract][Full Text] [Related]
16. Sequential molecular abnormalities are involved in the multistage development of squamous cell lung carcinoma.
Wistuba II; Behrens C; Milchgrub S; Bryant D; Hung J; Minna JD; Gazdar AF
Oncogene; 1999 Jan; 18(3):643-50. PubMed ID: 9989814
[TBL] [Abstract][Full Text] [Related]
17. Multiple genetic alterations in small-cell lung carcinoma.
Yokota J; Mori N; Akiyama T; Shimosato Y; Sugimura T; Terada M
Princess Takamatsu Symp; 1989; 20():43-8. PubMed ID: 2577337
[TBL] [Abstract][Full Text] [Related]
18. Deletion mapping of the short arm of chromosome 3 in Merkel cell carcinoma.
Leonard JH; Williams G; Walters MK; Nancarrow DJ; Rabbitts PH
Genes Chromosomes Cancer; 1996 Feb; 15(2):102-7. PubMed ID: 8834173
[TBL] [Abstract][Full Text] [Related]
19. Loss of heterozygosity at 5q21 in non-small cell lung cancer: a frequent event but without evidence of apc mutation.
Cooper CA; Bubb VJ; Smithson N; Carter RL; Gledhill S; Lamb D; Wyllie AH; Carey FA
J Pathol; 1996 Sep; 180(1):33-7. PubMed ID: 8943812
[TBL] [Abstract][Full Text] [Related]
20. [Significance of heterozygosity loss in the long arm of chromosome 5 (5q21) in small cell carcinoma of the lung].
Sánchez Céspedes M; López Cabrerizo MP; Moreno I; Ariza A; Monzó M; Rosell R
Med Clin (Barc); 1997 May; 109(1):1-5. PubMed ID: 9303970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
